The Blogging College and University President: Academic Leadership in the Age of Web 2.0

Blogs are certainly at the forefront of the Web 2.0 movement. Blogging has been alternatively categorized as both “the next big thing” (Gallo, 2004) and an “Internet Wasteland” (Anonymous, 2003). In a nutshell, a blog can be differentiated from a website in that it is an easier to create and update web vehicle, usually simply by typing into a preprogrammed interface. From a definitional perspective, a blog refers to an online journal that can be updated regularly, with entries typically displayed in chronological order. While blogs now encompass not only text, but video and audio as well, it is generally accepted that if the individual posts/items/articles that cannot be linked to separately via a permalink (rather then just linking to the whole site), then the site in question is not a blog. Blogs are also commonly referred to as a weblog or web log, with blog actually being the short form of these terms. Blog is also a verb, meaning to write an article on such an online journal

Back to the Future?: Why Old School Item Pricing Laws May Hold Back the Uses of RFID in Retail Settings

In an era of quickly advancing retail technology, 10 states and a number of major cities still mandate that individual price tags be placed on almost all items available for sale in grocery stores and other retail outlets. Research has shown that they are a major cost impediment for retail stores and a hidden tax facing consumers. At present, item pricing laws are also a factor in slowing adoption of RFID (radio frequency identification) technology in stores. The author provides an analysis of the present situation and recommendations for future action for retail and technology management

The Adoption of RFID Technology in the Retail Supply Chain

This article examines current developments regarding the adoption of RFID technology in the retail supply chain. An explanation is provided of what Radio Frequency Technology (RFID) is and how it works. The benefits of this technology to retailers are outlined in contrast to Bar Coding. Though the technology offers promise for retailers, it does present a number of concerns, which are outlined. Lastly, the article identifies research needs with regard to the new technology

Defect generation and deconfinement on corrugated topographies

We investigate topography-driven generation of defects in liquid crystals films coating frozen surfaces of spatially varying Gaussian curvature whose topology does not automatically require defects in the ground state. We study in particular disclination-unbinding transitions with increasing aspect ratio for a surface shaped as a Gaussian bump with an hexatic phase draped over it. The instability of a smooth ground state texture to the generation of a single defect is also discussed. Free boundary conditions for a single bump are considered as well as periodic arrays of bumps. Finally, we argue that defects on a bump encircled by an aligning wall undergo sharp deconfinement transitions as the aspect ratio of the surface is lowered.Comment: 24 page

Maintaining dose intensity of adjuvant chemotherapy in older patients with breast cancer

Maintaining the relative dose intensity (RDI) of adjuvant chemotherapy at\ua0≥ 85% has been associated with improved treatment outcomes in early-stage breast cancer (ESBC). Increasing evidence has suggested that patients aged\ua0≥ 65 years can maintain the optimal RDI for standard chemotherapy regimens. The present study investigated the RDI of newer adjuvant chemotherapy regimens in this demographic.We retrospectively analyzed the data from 281 patients aged\ua0≥ 65 years with a diagnosis of ESBC who had received adjuvant chemotherapy across 3 sites in Queensland, Australia from 2010 to 2015. The primary endpoint was the proportion of patients who had received an RDI of\ua0≥ 85%.The median age at diagnosis was 68 years (range, 65-85 years), with 36.3% aged > 70 years. The patient characteristics included tumor stage T3 or T4 in 17% and node-positive disease in 60%. The common chemotherapy regimens included docetaxel/cyclophosphamide (23%), 5-fluorouracil/epirubicin/cyclophosphamide plus docetaxel or paclitaxel (17%); Adriamycin/cyclophosphamide/weekly paclitaxel (38%); and docetaxel/carboplatin/trastuzumab (11%). Primary (15%) and secondary (54%) granulocyte colony-stimulating factor (G-CSF) was used. An RDI of\ua0≥ 85% was achieved in 63% of the patients. Significant associations were noted between a reduced RDI and age\ua0≥ 70 years (P\ua0< .001), Charlson comorbidity index\ua0≥ 1 (P\ua0= .043), initial dose reductions (P\ua0= .01), secondary G-CSF use (P\ua0= .45), hospital admission (P\ua0< .001), and febrile neutropenia (P\ua0= .007). Treatment-related toxicities were the most common reason for noncompletion, with high rates of hospital admissions (46%) and febrile neutropenia (22%).Our findings suggest that patients aged\ua0≥ 65 years with ESBC can maintain an optimal RDI with modern chemotherapy regimens. Appropriate geriatric assessment and the use of supportive measures such as G-CSF could better assist select groups to maintain an optimal dose intensity

ECCO Essential Requirements for Quality Cancer Care: Primary care.

ECCO Essential Requirements for Quality Cancer Care (ERQCC) are checklists and explanations of organisation and actions that are necessary to give high-quality care to cancer patients. They are written by European experts representing all disciplines involved in cancer care. This paper concerns the integration of primary care into care for all cancers in Europe. Primary care integration

The effects of a family-centered psychosocial-based nutrition intervention in patients with advanced cancer: the PiCNIC2 pilot randomised controlled trial

BACKGROUND: Malnutrition in advanced cancer patients is common but limited and inconclusive data exists on the effectiveness of nutrition interventions. Feasibility and acceptability of a novel family-based nutritional psychosocial intervention were established recently. The aims of this present study were to assess the feasibility of undertaking a randomised controlled trial of the latter intervention, to pilot test outcome measures and to explore preliminary outcomes.METHODS: Pilot randomised controlled trial recruiting advanced cancer patients and family caregivers in Australia and Hong Kong. Participants were randomised and assigned to one of two groups, either a family-centered nutritional intervention or the control group receiving usual care only. The intervention provided 2-3 h of direct dietitian contact time with patients and family members over a 4-6-week period. During the intervention, issues with nutrition impact symptoms and food or eating-related psychosocial concerns were addressed through nutrition counselling, with a focus on improving nutrition-related communication between the dyads and setting nutritional goals. Feasibility assessment included recruitment, consent rate, retention rate, and acceptability of assessment tools. Validated nutritional and quality of life self-reported measures were used to collect patient and caregiver outcome data, including the 3-day food diary, the Patient-Generated Subjective Global Assessment Short Form, the Functional Assessment Anorexia/Cachexia scale, Eating-related Distress or Enjoyment, and measures of self-efficacy, carers' distress, anxiety and depression.RESULTS: Seventy-four patients and 54 family caregivers participated in the study. Recruitment was challenging, and for every patient agreeing to participate, 14-31 patients had to be screened. The consent rate was 44% in patients and 55% in caregivers. Only half the participants completed the trial's final assessment. The data showed promise for some patient outcomes in the intervention group, particularly with improvements in eating-related distress (p = 0.046 in the Australian data; p = 0.07 in the Hong Kong data), eating-related enjoyment (p = 0.024, Hong Kong data) and quality of life (p = 0.045, Australian data). Energy and protein intake also increased in a clinically meaningful way. Caregiver data on eating-related distress, anxiety, depression and caregiving burden, however, showed little or no change.CONCLUSIONS: Despite challenges with participant recruitment, the intervention demonstrates good potential to have positive effects on patients' nutritional status and eating-related distress. The results of this trial warrant a larger and fully-powered trial to ascertain the effectiveness of this intervention.TRIAL REGISTRATION: The trial was registered with the Australian &amp; New Zealand Clinical Trials Registry, registration number ACTRN12618001352291 .</p

Sex differences in the diagnosis of advanced cancer and subsequent outcome in people with chronic kidney disease: an analysis of a national population cohort

Background: In the general population, advanced cancer stage at presentation is associated with poorer health outcomes. People with chronic kidney disease (CKD) have increased incidence and mortality from most cancer types. We sought to determine whether people with CKD were more likely to present with advanced stage cancer, whether this was associated with survival, and whether these associations varied by sex. Methods: Data were from Secure Anonymised Information Linkage Databank (SAIL), a Welsh primary care database with linkage to cancer and death registries. We included patients with a de- novo cancer diagnosis (2011-2017), and at least two kidney function tests in the two years prior to diagnosis. Estimated glomerular filtration rate based on serum creatinine (eGFRcr) was calculated using the CKD-EPI 2009 equation (mL/min/1.73m2). Logistic regression models determined odds of presenting with advanced cancer (stage 3 or 4 at diagnosis) by different values of eGFRcr at baseline. Cox proportional hazards models tested associations between eGFRcr at baseline and all-cause mortality risk (reference eGFR 75 to &lt;90). Findings: There were 66,128 patients: 30,857 (46.7%) were female, mean age was 69.1 (standard deviation [SD] 13.8) years in females and 70.6 (SD 11.1) years in males; median eGFRcr at baseline was 78 (interquartile range [IQR] 63 – 90) mL/min/1.73m2 in both females and males. Over a median follow-up time of 3.1 (IQR 0.5 – 5.7) years in females and 2.9 (IQR 0.5-5.5) years in males, there were 17,303 deaths in females and 20,855 in males. An eGFRcr &lt;30 was associated with higher odds of presenting with advanced cancer in males (OR 1.33 95% CI 1.09-1.62), but not in females (OR 1.17 95% CI 0.92-1.50); positive associations were primarily driven by prostate and breast cancers. With lower eGFRcr, hazards of cancer death increased in both sexes, but lower eGFRcr was associated with greater hazards of cancer death in females (eGFRcr &lt;30: HR 1.71, 95% CI 1.56-1.88, p&lt;0.001; male versus female comparison HR 0.88, 95% CI 0.78-0.90; p=0.037). Interpretation: CKD was not associated with substantially higher odds of presenting with advanced cancer across most cancer sites (except prostate and breast), but was associated with reduced survival. Despite an initial survival advantage compared to males, females with CKD had disproportionately higher hazards of death. Though potential explanations for reduced survival after a cancer diagnosis are manifold, scrutiny of access to, efficacy, and safety of cancer treatments in people with CKD – particularly females with CKD – are warranted

Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study

Background: Exercise interventions during adjuvant cancer therapy have been shown to increase functional capacity, relieve fatigue and distress and may assist rates of chemotherapy completion. These studies have been limited to breast, gastric and mixed cancer groups and it is not yet known if a similar intervention is even feasible among women with ovarian cancer. We aimed to assess safety, feasibility and potential effect of a walking intervention in women undergoing chemotherapy for ovarian cancer